Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders (Q34212933)

31 July 2017

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders (English)

1 reference

cognitive behavioral therapy

31 July 2017

0 references

1 reference

1

Douglas A Drossman

1 reference

31 July 2017

Brenda B Toner

2

1 reference

31 July 2017

William E Whitehead

3

1 reference

31 July 2017

Nicholas E Diamant

4

1 reference

31 July 2017

Chris B Dalton

5

1 reference

31 July 2017

Susan Duncan

6

1 reference

31 July 2017

Shelagh Emmott

7

1 reference

31 July 2017

Valerie Proffitt

8

1 reference

31 July 2017

Donna Akman

9

1 reference

31 July 2017

Karen Frusciante

10

1 reference

31 July 2017

Terry Le

11

1 reference

31 July 2017

Kim Meyer

12

1 reference

31 July 2017

Barbara Bradshaw

13

1 reference

31 July 2017

Kristi Mikula

14

1 reference

31 July 2017

Carolyn B Morris

15

1 reference

31 July 2017

Carlar J Blackman

16

1 reference

31 July 2017

Yuming Hu

17

1 reference

31 July 2017

Huanguang Jia

18

1 reference

31 July 2017

Jim Z Li

19

1 reference

31 July 2017

Gary G Koch

20

1 reference

31 July 2017

Shrikant I Bangdiwala

21

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

31 July 2017

1 reference

31 July 2017

125

1 reference

31 July 2017

1

1 reference

31 July 2017

19-31

1 reference

AGA technical review on irritable bowel syndrome

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

What determines severity among patients with painful functional bowel disorders?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Antidepressants for functional gastrointestinal syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Psychotropic agents in irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Sexual and physical abuse in women with functional or organic gastrointestinal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Effects of coping on health outcome among women with gastrointestinal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Health status by gastrointestinal diagnosis and abuse history.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

The McGill Pain Questionnaire: Major properties and scoring methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Functional bowel disorders. A multicenter comparison of health status and development of illness severity index

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Credibility of analogue therapy rationales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

The development of a cognitive scale for functional bowel disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Cognitive-behavioral group therapy for patients with irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Quality of life in persons with irritable bowel syndrome: development and validation of a new measure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Using numerical results from systematic reviews in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Multiple testing in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Procedures for comparing samples with multiple endpoints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Some large-sample distribution-free estimators and tests for multivariate partially incomplete data from two populations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Hypnotherapy in severe irritable bowel syndrome: further experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Comparison of desipramine and cognitive/behavioral therapy in the treatment of elderly outpatients with mild-to-moderate depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Effects of desipramine on irritable bowel syndrome compared with atropine and placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Do antidepressants have an analgesic effect in psychogenic pain and somatoform pain disorder? A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

American Gastroenterological Association medical position statement on anorectal testing techniques. American Gastroenterological Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

inferred from DOI database lookup

7 January 2021

based on heuristic

A controlled trial of psychological treatment for the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900669-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0016-5085(03)00669-3

1 reference

31 July 2017

1 reference